Reference - RRC(Research Resource Circulation)

Species	Resource	RRC ID	Title	Journal	Published	Link
DNA material	tFucci(CA)2/pCSII-EF (RDB15446)	81893	A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib.	Cell Rep Med	2024-9-17	Pubmed Full text
Human and Animal Cells	HuH-7	78770	Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.	Cancer Sci	2023-12-1	Pubmed Full text
Human and Animal Cells	CACO-2(RCB0988)	76986	Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS^G12D Inhibitor, in Colorectal Cancer Treatment.	Anticancer Res	2023-10-1	Pubmed Full text
Human and Animal Cells , DNA material	II-18(RCB2093) , tFucci(CA)2/pCSII-EF (RDB15446)	76706	L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.	Cell Rep Med	2023-8-3	Pubmed Full text
Human and Animal Cells	TE-1(RCB1894) , TE-4(RCB2097) , TE-5(RCB1949) , TE-8(RCB2098)	62767	Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.	J Nucl Med	2016-7-1	Pubmed Full text
Human and Animal Cells	SAS(RCB1974) , Sa3(RCB0980) , HSC-3(RCB1975)	58015	Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.	Sci Rep	2019-8-21	Pubmed Full text

Reference - List